Author

Irene Boluda-Luis

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CRISPR screen· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Ariadna Quer· 1 shared Conxi LázaroiD· 1 shared Eduard SerraiD· 1 shared Elisabeth CastellanosiD· 1 shared Emilio AmilibiaiD· 1 shared Gemma Casals-SendraiD· 1 shared Ignacio BlancoiD· 1 shared Ignasi Jarne-SanziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Ariadna Quer

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

NF2 lacking exon 11 isoform induced by antisense gene therapy is able to recover partially merlin deficiency on NF2-related Schwannomatosis iPSC-derived spheroid model

Gemma Casals-Sendra, Ignasi Jarne-Sanz, Núria Catasús, Irene Boluda-Luis, Ariadna Quer, Emilio Amilibia, Scott Randall Plotkin, Conxi Lázaro, Eduard Serra, Ignacio Blanco, Elisabeth Castellanos

This study shows that antisense gene therapy using PMOs can induce exon 11 skipping in NF2-deficient Schwann cells, partially restoring merlin function and key pathways in a spheroid model of NF2-SWN.

Molecular Therapy — Nucleic Acids · Aug 3, 2026Peer-reviewedGenetics